Stevens R, Silverman M, Mistry N, Biernat L, Guedes K. Phase 1 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of the Selective Oral CCR2 Antagonist CNTX-6970 in Healthy Subjects [abstract]. Presented at: PAINWeek 2019, Las Vegas, Nevada, September 3-7, 2019.